Journal Article

Polymorphisms and haplotypes of the <i>NBS1</i> gene are associated with risk of sporadic breast cancer in non-Hispanic white women ≤55 years

Jiachun Lu, Qingyi Wei, Melissa L. Bondy, Donghui Li, Abenaa Brewster, Sanjay Shete, Tse-Kuan Yu, Aysegul Sahin, Funda Meric-Bernstam, Kelly K. Hunt, S.Eva Singletary, Merrick I. Ross and Li-E Wang

in Carcinogenesis

Volume 27, issue 11, pages 2209-2216
ISSN: 0143-3334
Published online May 2006 | e-ISSN: 1460-2180 | DOI:
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women ≤55 years

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


DNA double-strand breaks (DSBs) may lead to genomic instability and cancer if unrepaired. Nijmegen breakage syndrome 1 (NBS1) protein is one of the key proteins that participates in recognition and repair of DSBs in humans. We hypothesized that polymorphisms of NBS1 are associated with breast cancer risk. We selected three NBS1 haplotype-tagging polymorphisms (i.e. 924T>C, 8360G>C and 30537G>C) to represent all common (≥5%) haplotypes reported in the National Institute of Environmental Health Sciences database and to reconstruct haplotypes. In a hospital-based case–control study of 421 non-Hispanic white patients with sporadic breast cancer (≤55 years) and 423 cancer-free controls who were frequency-matched with the cases by age (±5 years and ≤55), we tested our hypothesis and found that compared with 924TT homozygotes the variant homozygote 924CC carriers had a 4.55-fold increased risk of breast cancer [95% confidence interval (CI) = 1.51–13.7] and that compared with the 8360GG genotype the variant genotypes were also associated with a significantly increased risk [adjusted odds ratio (OR) = 1.33, 95% CI = 1.00–1.78 for 8360CG; adjusted OR = 1.83, 95% CI = 1.14–2.94 for 8360CC]. However, these effects were not observed for the 30537G>C polymorphism. Furthermore, the derived haplotypes were associated with risk in a dose–response manner as the number of variant (risk) alleles (i.e. 8360C, 924C or 30537C) increased (adjusted OR = 1.07, 95% CI = 0.78–1.46 for 1–2 variant alleles; adjusted OR = 2.47, 95% CI = 1.48–4.14 for 3–6 variant alleles; Ptrend = 0.006). These findings suggest that NBS1 polymorphisms and haplotypes may contribute to the etiology of sporadic breast cancer in young non-Hispanic white women. Large studies are warranted to confirm these findings.

Journal Article.  7224 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.